Pharmacophore an International Research Journal
Pharmacophore
Submit Manuscript
Open Access | Published: 2020 - Issue 1

Antitumor Activity of Alkaloids Extract from Opuntia Polyacantha Plant Using High Content Screening Technique (HCS) ‎‎ Download PDF


Abtisam F. Al-Shukri, Farah A. Al-Marzook, Nawal A. Al-Hammadi, Iman H. Mutlag
Abstract

Background/aim: Multipara metric toxicity analyses at the individual cell level using cellular imaging-based methods such as High Content Screening (HCS) play a crucial role in detecting toxicity. The positive result of the toxicity on cancer cell increase with increasing concentration. This study aimed to assess the potential effect of alkaloid extract on breast cancer cells.                Material and Methods: Opuntia polyacantha leaves were separately extracted with 80% methanol, and chloroform at pH 2 and 10, and the chloroform portion was dried to obtain the total alkaloid extract. The total alkaloid was qualitatively detected by Hager’s, Dragendorff’s, and Mayer’s reagents. The cytotoxic effect of Opuntia polyacantha alkaloids extract was examined in one-cultured cellular models (MCF7 breast cancer cell line) by HCS. The inhibitory effect of Opuntia polyacantha on MCF7 cell growth was due to the induction of apoptosis. Result: The study found that alkaloid extract of Opuntia polyacantha has the ability to reduce the viability of breast cancer cells by nuclear condensation, cell membrane permeability, disrupting Mitochondrial Membrane Potential (MMP), fragmentation and releasing cytochrome c from the mitochondria into the cytosol. Thus, Opuntia polyacantha is a potential MCF7 inhibitor compared to doxorubicin as the positive control. Conclusion: In this study, data showed that Opuntia polyacantha might have therapeutic value in breast cancer treatment worthy of further attention.

Cite this article

QR code:

Short Link:
Quick Access

Associations

Pharmacophore
ISSN: 2229-5402

Copyright © 2024 Pharmacophore. Authors retain copyright of their article if they are accepted for publication.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.